Skip to content
10-Q

Quarterly Report

Arena Pharmaceuticals, Inc.

0001080709-21-000031

← back to feed
Filed
Aug 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 29, 2021 61.07M sh
Shares Diluted Q2 2021 · Jun 30, 2021 60.79M sh
Shares Diluted Q2 2021 · Jun 30, 2021 60.29M sh
Shares Diluted Q2 2021 · Jun 30, 2020 52.77M sh
Shares Diluted Q2 2021 · Jun 30, 2020 51.5M sh
Capex Q2 2021 · Jun 30, 2021 $302K
Capex Q2 2021 · Jun 30, 2020 $562K
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$213.83M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$171.8M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $514.18M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $219.54M
Stockholders Equity Q2 2021 · Jun 30, 2021 $971.08M
Stockholders Equity Q2 2021 · Mar 31, 2021 $1.09B
Stockholders Equity Q2 2021 · Dec 31, 2020 $1.08B
Stockholders Equity Q2 2021 · Jun 30, 2020 $1.24B
Stockholders Equity Q2 2021 · Mar 31, 2020 $988.49M
Stockholders Equity Q2 2021 · Dec 31, 2019 $1.07B
Current Liabilities Q2 2021 · Jun 30, 2021 $64.84M
Current Liabilities Q2 2021 · Dec 31, 2020 $58.08M
Current Assets Q2 2021 · Jun 30, 2021 $990.44M
Current Assets Q2 2021 · Dec 31, 2020 $1.14B
Total Assets Q2 2021 · Jun 30, 2021 $1.08B
Total Assets Q2 2021 · Dec 31, 2020 $1.19B
Eps Diluted Q2 2021 · Jun 30, 2021 −$2.40
Eps Diluted Q2 2021 · Jun 30, 2021 −$4.39
Eps Diluted Q2 2021 · Jun 30, 2020 −$1.61
Eps Diluted Q2 2021 · Jun 30, 2020 −$3.59
Eps Basic Q2 2021 · Jun 30, 2021 −$2.40
Eps Basic Q2 2021 · Jun 30, 2021 −$4.39
Eps Basic Q2 2021 · Jun 30, 2020 −$1.61
Eps Basic Q2 2021 · Jun 30, 2020 −$3.59
Sga Expense Q2 2021 · Jun 30, 2021 $31.94M
Sga Expense Q2 2021 · Jun 30, 2021 $61.4M
Sga Expense Q2 2021 · Jun 30, 2020 $22.88M
Sga Expense Q2 2021 · Jun 30, 2020 $49.32M
Rd Expense Q2 2021 · Jun 30, 2021 $112.45M
Rd Expense Q2 2021 · Jun 30, 2021 $214.99M
Rd Expense Q2 2021 · Jun 30, 2020 $64.95M
Rd Expense Q2 2021 · Jun 30, 2020 $143.48M
Net Income Q2 2021 · Jun 30, 2021 −$146.1M
Net Income Q2 2021 · Jun 30, 2021 −$264.51M
Net Income Q2 2021 · Mar 31, 2021 −$118.42M
Net Income Q2 2021 · Jun 30, 2020 −$84.93M
Net Income Q2 2021 · Jun 30, 2020 −$185.14M
Net Income Q2 2021 · Mar 31, 2020 −$100.21M
Operating Income Q2 2021 · Jun 30, 2021 −$144.39M
Operating Income Q2 2021 · Jun 30, 2021 −$276.38M
Operating Income Q2 2021 · Jun 30, 2020 −$87.82M
Operating Income Q2 2021 · Jun 30, 2020 −$192.54M
Revenue Q2 2021 · Jun 30, 2021 $0
Revenue Q2 2021 · Jun 30, 2021 $0
Revenue Q2 2021 · Jun 30, 2020 $0
Revenue Q2 2021 · Jun 30, 2020 $262K